
At the February 2015 ACIP meeting held last month, recommendations were made for meningococcal, influenza, and HPV vaccines. The updated recommendations for meningococcal and HPV vaccines were particularly important, as they each come with unique challenges.
You may have missed the recent webinars hosted by NFID, discussing how to overcome these challenges, but archived versions of the webinars are available online at www.nfid.org/webinars:
The Role of New Serogroup B Vaccines in Preventing Meningitis Outbreaks: NFID experts, Carol J. Baker, MD, Lorry G. Rubin, MD, and William Schaffner, MD, discuss unique challenges of meningococcal disease, new ACIP recommendations for serogroup B vaccine use, and considerations for future recommendations.
Five Key Steps to Improve HPV Vaccination Rates in Your Practice: Joseph A. Bocchini, Jr., MD and Noel T. Brewer, PhD discuss HPV vaccination barriers and opportunities and will present five key steps that healthcare professionals (HCPs) can take to improve HPV vaccination rates in their practices, based on the NFID Call to Action, HPV Vaccination as a Public Health Priority.
Related Posts

Autism and Vaccines: What the Science Really Says
Progress is being made in the search for the causes of autism, and this information may be valuable for families who are hesitant about vaccines

News Round-Up: Infectious Disease Threats
According to NFID website poll, there are several worrisome infectious disease threats. Read recent news on topics of greatest concern, including avian influenza (bird flu), measles, and respiratory syncytial virus (RSV) …

Vaccines and Heart Health: A Vital Connection
Heart disease can increase the risk of serious or fatal complications from respiratory diseases including COVID-19, flu, and RSV